Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side [...]
Donanemab is not a cure and comes with significant side [...]
The drug, Leqembi, may modestly slow cognitive decline in early [...]
The report said the F.D.A.’s approval process for Aduhelm was [...]
Preliminary results offer hope that gene therapy can protect people [...]
The drug, lecanemab, made by Eisai and Biogen, also carried [...]
Regulators must balance patient’s needs with their safety.
Biogen and Eisai reported the finding from a large late-stage [...]
The drug, crenezumab, failed to prevent early symptoms or slow [...]
The drug company will effectively give up on marketing Aduhelm, [...]
Studies linked to Cassava Sciences, once a stock market favorite, [...]